ARGENICA THERAPEUTICS LIMITED - News & Media

Market Cap $100.4M Add to my watchlist

Argenica Therapeutics Limited is an Australia-based clinical drug development company.... Argenica Therapeutics Limited is an Australia-based clinical drug development company. The Company is focused on developing therapeutics to reduce brain tissue death after stroke and other types of brain injury and neurodegenerative diseases to improve patient outcomes. The Company's lead candidate, ARG-007, is a cationic arginine-rich peptide that aims to protect brain cells and reduce cell death following a stroke, and other types of neural injury, in order to minimize the impact of these conditions and improve patient recovery. ARG-007 has been successfully demonstrated to improve outcomes in pre-clinical stroke models, traumatic brain injury (TBI) and hypoxic ischaemic encephalopathy (HIE). More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

No News & Media currently available.

(20min delay)
Last 70.0¢		Change 0.040(6.06%)		Mkt cap ! $100.4M

Open	High	Low	Value	Volume
67.0¢	70.0¢	66.0¢	$122.1K	183.2K

Buyers (Bids)

No.	Vol.	Price($)
1	4469	67.0¢

Sellers (Offers)

Price($)	Vol.	No.
70.0¢	44310	3

Last trade - 16.10pm 03/12/2024 (20 minute delay)


Last 68.0¢		Change 0.040 ( 3.03 %)
Open	High	Low	Volume
67.0¢	68.0¢	66.0¢	37628
Last updated 14.08pm 03/12/2024 ?

AGN (ASX) Chart